238 related articles for article (PubMed ID: 14207786)
1. THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.
STAFFORD JL
J Clin Pathol; 1964 Sep; 17(5):520-30. PubMed ID: 14207786
[No Abstract] [Full Text] [Related]
2. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
Sindet-Pedersen S
Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
[TBL] [Abstract][Full Text] [Related]
3. On the mechanism of thrombosis.
Wessler S; Yin ET
Prog Hematol; 1969; 6():201-32. PubMed ID: 4889323
[No Abstract] [Full Text] [Related]
4. Human fibrinogen.
Shafer JA; Higgins DL
Crit Rev Clin Lab Sci; 1988; 26(1):1-41. PubMed ID: 3286116
[TBL] [Abstract][Full Text] [Related]
5. FIBRINOLYSIS AND INTRINSIC HAEMOSTASIS.
STAFFORD JL
Br Med Bull; 1964 Sep; 20():179-84. PubMed ID: 14209756
[No Abstract] [Full Text] [Related]
6. [From fibrinogen to fibrin and its dissolution].
Juhan-Vague I; Hans M
Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455
[TBL] [Abstract][Full Text] [Related]
7. Disorders of Fibrinogen and Fibrinolysis.
May JE; Wolberg AS; Lim MY
Hematol Oncol Clin North Am; 2021 Dec; 35(6):1197-1217. PubMed ID: 34404562
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
Jespersen J
Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
[TBL] [Abstract][Full Text] [Related]
9. [Effects of tissue-type plasminogen activator from a culture of calf kidney cells on hemostasis and fibrinolysis in experimental nephritis].
Andreenko GV; Podorol'skaia LV; Serebriakova TN; Liaginskiĭ AV; Egorov BB
Biull Eksp Biol Med; 1988 Oct; 106(10):424-6. PubMed ID: 3142531
[TBL] [Abstract][Full Text] [Related]
10. Kinetic characterization of hemostasis in thermal injury.
Simon TL; Curreri PW; Harker LA
J Lab Clin Med; 1977 Apr; 89(4):702-11. PubMed ID: 845474
[TBL] [Abstract][Full Text] [Related]
11. Concepts of clot lysis.
Francis CW; Marder VJ
Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790
[TBL] [Abstract][Full Text] [Related]
12. Influence of fibrinogen split products on platelets.
Barnhart MI; Cress DC; Henry RL; Riddle JM
Thromb Diath Haemorrh; 1967 Feb; 17(1-2):78-98. PubMed ID: 4869431
[No Abstract] [Full Text] [Related]
13. Lipoproteins and thrombosis: effects of lipid lowering.
Miller GJ
Curr Opin Lipidol; 1995 Feb; 6(1):38-42. PubMed ID: 7735714
[TBL] [Abstract][Full Text] [Related]
14. What drives "fibrinolysis"?
Medcalf RL
Hamostaseologie; 2015; 35(4):303-10. PubMed ID: 25564072
[TBL] [Abstract][Full Text] [Related]
15. [Interpretation of hemostatic and fibrinolytic markers].
Asakura H
Rinsho Byori; 2011 Oct; 59(10):970-7. PubMed ID: 22184880
[TBL] [Abstract][Full Text] [Related]
16. [The role of lipids and lipoproteins in hemostatic processes].
Worowski K; Farbiszewski R
Postepy Biochem; 1970; 16(1):51-66. PubMed ID: 4907179
[No Abstract] [Full Text] [Related]
17. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass.
de Haan J; Schönberger J; Haan J; van Oeveren W; Eijgelaar A
J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1017-23. PubMed ID: 8246533
[TBL] [Abstract][Full Text] [Related]
18. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
Collatos C; Barton MH; Prasse KW; Moore JN
J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
[TBL] [Abstract][Full Text] [Related]
19. Thrombus formation with rehydrated, lyophilized platelets.
Fischer TH; Merricks EP; Bode AP; Bellinger DA; Russell K; Reddick R; Sanders WE; Nichols TC; Read MS
Hematology; 2002 Dec; 7(6):359-69. PubMed ID: 12475741
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of pre-analytical, demographic, behavioural and metabolic variables on fibrinolysis and haemostasis activation markers utilised to assess hypercoagulability.
Stegnar M; Cuderman TV; Bozic M
Clin Chem Lab Med; 2007; 45(1):40-6. PubMed ID: 17243913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
